MODERNA CONSIDERS PRICE OF $110-$130 FOR COVID-19 VACCINE - WSJ
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
151 USD | -2.38% | +5.93% | +51.85% |
08/06 | US FDA expands GSK's RSV vaccine approval to adults aged 50 to 59 | RE |
07/06 | Moderna Files With FDA for Updated Covid Shot | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B | |
-9.14% | 11.06B |
- Stock Market
- Equities
- MRNA Stock
- News Moderna, Inc.
- Moderna Considers Price Of $110-$130 For Covid-19 Vaccine - Wsj…